JACC: CardioOncology - Arterial Thromboembolism in Japanese Cancer Patients: Incidence, Predictors, and Survival Impact
Commentary by Yugo Yamashita

Commentary by Yugo Yamashita
Commentary by Brian Jensen
Commentary by Saro Armenian
Commentary by Saro Armenian
Drs. Eugene Yang and Amber Tang discuss social determinants and impact on cardiovascular risk factors among disaggregated Asian subgroups.
JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and David Austin, MD, FRCP discuss PROACT, a phase three randomized open label blinded endpoint superiority trial of enalapril to prevent anthracycline induced cardiotoxicity.
Audio Summary of the March Issue with Introduction by Dr. Bonnie Ky.
Commentary by Bonnie Ky
Commentary by Gabriel Aleixo
Commentary by Corralea Kappel
Audio Summary of the April 1, 2024 Issue by Dr. Jian'an Wang
Commentary by Dr. Abdullah Al-Abcha and Dr. John Blair
Commentary by Dr Yundai Chen
Commentary by Dr Pranav M. Patel
Commentary by Dr Dong Zhao
Commentary by Dr. Mirza Umair Khalid and Dr. Oriol Rodriguez-Leor
Commentary by Dr. Mirza Umair Khalid and Dr. Mohamed Abdel-Wahab
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides and Dr. James Kirkpatrick
Commentary by Dr. Candice Silversides
Commentary by Dr. Sadeer Al-Kindi and Dr. Allan Sniderman
Commentary by Dr. Candice Silversides and Dr. Anna Bortnick
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides